However, this particular αPD-L1 clone, 10F.9G2, has multiple mechanisms of action and can, besides the blockade of the PD-1/PD-L1 axis, directly deplete tumor cells as well as certain myeloid populations within the tumor [37]. The gene discussed is CD274; the disease is neoplasm.